Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial.
Leboulleux S, Bournaud C, Chougnet CN, Lamartina L, Zerdoud S, Do Cao C, Catargi B, Dygai I, Kelly A, Barge ML, Vera P, Rusu D, Schneegans O, Roux J, Raymond P, Benisvy D, Eberle MC, Bidault S, Nascimento C, Bastie D, Giraudet AL, Bardet S, Le Moullec N, Roudaut N, Drui D, Godbert Y, Zalzali M, Drutel A, Morel O, Velayoudom FL, Al Ghuzlan A, Schlumberger M, Buffet C, Borget I.
Leboulleux S, et al. Among authors: roux j.
Lancet Diabetes Endocrinol. 2024 Nov 22:S2213-8587(24)00276-6. doi: 10.1016/S2213-8587(24)00276-6. Online ahead of print.
Lancet Diabetes Endocrinol. 2024.
PMID: 39586309